Biosergen AB (FRA:8N1) Inventories, Work In Process : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Biosergen AB's work in process for the quarter that ended in Sep. 2024 was €0.00 Mil.

Biosergen AB Inventories, Work In Process Historical Data

The historical data trend for Biosergen AB's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Inventories, Work In Process Chart

Biosergen AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Inventories, Work In Process

Biosergen AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Inventories, Work In Process	Get a 7-Day Free Trial											-	-	-	-	-

Biosergen AB Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Biosergen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (FRA:8N1) » Definitions » Inventories, Work In Process

Comparable Companies

Traded in Other Exchanges

BIOSGN:Sweden

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines